Everolimus in Combination With Exemestane in the Treatment of Postmenopausal Women With Estrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer Who Are Refractory to Letrozole or Anastrozole
Clinical trial NCT00863655 · COMPLETED
Trial details
- NCT number
- NCT00863655
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-06-03
- Primary completion
- 2014-12-04
- Enrollment
- 724
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.